These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20347863)

  • 1. Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.
    Antzoulatos E; Jakowec MW; Petzinger GM; Wood RI
    Pharmacol Biochem Behav; 2010 Jun; 95(4):466-72. PubMed ID: 20347863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.
    Sconce MD; Churchill MJ; Greene RE; Meshul CK
    Neuroscience; 2015 Jul; 299():156-74. PubMed ID: 25943481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of gait and neurochemical correlation in a classical murine model of Parkinson's disease.
    Wang XH; Lu G; Hu X; Tsang KS; Kwong WH; Wu FX; Meng HW; Jiang S; Liu SW; Ng HK; Poon WS
    BMC Neurosci; 2012 Nov; 13():142. PubMed ID: 23151254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
    Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson's disease by increasing expression of BNDF.
    Ji C; Xue GF; Lijun C; Feng P; Li D; Li L; Li G; Hölscher C
    Brain Res; 2016 Mar; 1634():1-11. PubMed ID: 26453833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.
    Petroske E; Meredith GE; Callen S; Totterdell S; Lau YS
    Neuroscience; 2001; 106(3):589-601. PubMed ID: 11591459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of crocin on substantia nigra in MPTP-induced Parkinson's disease model of mice.
    Haeri P; Mohammadipour A; Heidari Z; Ebrahimzadeh-Bideskan A
    Anat Sci Int; 2019 Jan; 94(1):119-127. PubMed ID: 30159851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences.
    Sedelis M; Hofele K; Auburger GW; Morgan S; Huston JP; Schwarting RK
    Behav Genet; 2000 May; 30(3):171-82. PubMed ID: 11105391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of lixisenatide and liraglutide in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
    Liu W; Jalewa J; Sharma M; Li G; Li L; Hölscher C
    Neuroscience; 2015 Sep; 303():42-50. PubMed ID: 26141845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of estrogen and levodopa in 1-methyl-4-pheny-l-1, 2, 3, 6-tetrahydropyridine (mptp)-induced cognitive deficit in Parkinsonian ovariectomized mice model: A comparative study.
    Yadav SK; Pandey S; Singh B
    J Chem Neuroanat; 2017 Nov; 85():50-59. PubMed ID: 28711564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
    Yang W; Chen YH; Liu H; Qu HD
    Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (-)-sesamin on motor and memory deficits in an MPTP-lesioned mouse model of Parkinson's disease treated with l-DOPA.
    Zhao TT; Shin KS; Kim KS; Park HJ; Kim HJ; Lee KE; Lee MK
    Neuroscience; 2016 Dec; 339():644-654. PubMed ID: 27789382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photobiomodulation preserves behaviour and midbrain dopaminergic cells from MPTP toxicity: evidence from two mouse strains.
    Moro C; Torres N; El Massri N; Ratel D; Johnstone DM; Stone J; Mitrofanis J; Benabid AL
    BMC Neurosci; 2013 Mar; 14():40. PubMed ID: 23531041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
    Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
    Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
    Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sex and gonadectomy on brain MPTP toxicity and response to dutasteride treatment in mice.
    Isenbrandt A; Morissette M; Bourque M; Lamontagne-Proulx J; Coulombe K; Soulet D; Di Paolo T
    Neuropharmacology; 2021 Dec; 201():108784. PubMed ID: 34555366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism.
    Rozas G; López-Martín E; Guerra MJ; Labandeira-García JL
    J Neurosci Methods; 1998 Sep; 83(2):165-75. PubMed ID: 9765130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.